Medical Device Reprocessing Market expected to grow 2-fold over next 5 years

Medical Device Reprocessing Market expected to grow 2-fold over next 5 years

MarketsandMarkets, a market research firm, forecasts that the Medical Device Reprocessing Market is expected to more than double in size over the next 5 years. The recently published research report: “Medical Device Reprocessing Market by Product (Reprocessed Device (Catheter, Endoscope, Laparoscopic Instruments, Biopsy, Pulse Oximeter), Service), Application (Cardiology, Gastroenterology, Arthroscopy, Orthopedic, Anesthesia) – Global Forecast to 2022″, estimates that the Medical Device Reprocessing Market is expected to reach USD 1,754 Million by 2022 from an estimated USD 823.5 Million in 2017, at a CAGR of 16.3%. Read More.

 

Medline Industries Opens New Factory in Redmond, OR

Oregon’s The Bulletin reported on the opening of a new medical device reprocessing factory in its state. Medline Industries recently opened a new $12 million office and manufacturing facility in Redmond’s Desert Rise industrial park. According to the article, the factory “employs about 165 people, most of whom are involved in washing, sharpening and testing more than 1,000 different items, from compression sleeves to electronic surgical tools.” Medline ReNewal, an AMDR member, is the medical device reprocessing division of Medline Industries.

Medical device reprocessing is regulated by the U.S. Food and Drug Administration, which must approve single-use devices for re-use. Medline and other companies that gather the devices from hospitals and surgery centers become the manufacturers of record, according to Medline ReNewal’s vice president of operations, Steve Bettis. Medline ReNewal is part of the $500 million a year medical device reprocessing industry that includes fellow AMDR members Hygia Health Services, Innovative Health, Stryker Sustainability Solutions, and Vanguard AG of Germany. Read More.

AMDR, Reprocessing Take the Global Stage

Dan Vukelich, AMDR’s president, presented at two industry events in The Netherlands this week. During the ReMaTec 2017 trade show, which focused on the global remanufacturing industry, Dan Vukelich was a panelist for the EU roundtable.  The next stop was Informa’s MedTech Summit, where Dan presented alongside Arjan van Drongelen of the Netherlands, on the latest updates on the reprocessing of single-use devices and implications for industry in light of the new European Medical Device Regulation. 

Dan at ReMaTec 2017

AMDR’s Quarterly Newsletter – Summer Edition

AMDR recently launched its newly formatted quarterly newsletter. The Summer edition of the newsletter includes a round up of events, AMDR news, reprocessing industry coverage and sustainability in healthcare. The newsletter, which is free, can be accessed at bit.ly/AMDRSummer17.  New subscribers can sign up to receive the AMDR Quarterly Newsletter at http://www.amdr.org/subscribe/.

 

 

 

 

 

A win for the reprocessing industry today! U.S. Supreme Court rules in favor of Impression Products, Inc.

AMDR is thrilled to announce that our efforts at the U.S. Supreme Court – where we joined advocacy groups, non-profits and many leading technology companies and filed an amicus curiae brief in support of Impression Products – have been successful. Today the U.S. Supreme Court ruled in favor of Impression Products (Impression Products Inc. vs. Lexmark, Inc.), reinforcing the long standing importance of the first sale/patent exhaustion doctrine, which makes it possible for the reprocessing industry – and many other commercial products –  to remain available to consumers.  Read the full Supreme Court ruling here. Public Knowledge offers analysis of the ruling here. For a look back at the case’s relevance, check out Fortune’s article from March 2017.

Practice Greenhealth Releases 2016 Sustainability Benchmark Report

Practice Greenhealth has announced the availability of its 2016 Sustainability Benchmark Report.

Report Highlights:

“Third-party reprocessing of certain FDA-approved single-use medical devices offers huge benefits to the hospital in driving down RMW tonnage and disposal fees while also dramatically reducing the up-front purchase cost for a reprocessed versus a virgin device (often by around 50 percent). It is important to note that there are two aspects to a reprocessing program—the collection of devices bound for reprocessing and the subsequent buy-back of the reprocessed devices. While the collection of devices for reprocessing can offer significant avoided waste tonnage, the bulk of the cost savings and environmental impact reduction is in the buy-back of reprocessed devices. Medical device reprocessing has continued to grow within Practice Greenhealth member hospitals as evidenced by the yearly savings and tonnage growth indicated…”

The report also notes that to maximize reprocessing savings, hospitals must remain vigilant in managing their program. 

”…Purchasing reprocessed devices also requires considerable negotiation with suppliers—some of whom insert carefully written contract requirements for a certain portion of virgin devices that must be purchased for every reprocessed device bought back. Knowledgeable buy-back can sometimes be a slower implementation process. ….Supply chain leadership is key in negotiating these contracts.”

Read More. (full access for Practice Greenhealth members)

Zion Research Report: Global Reprocessed Medical Devices Market Expected to Reach over $4bn by 2021

 

 

 

Source: Shawn Morgan, QWTJ LIVE

Zion Research has published a new report titled “Reprocessed Medical Devices Market (Cardiovascular Medical Devices, Laparoscopic Medical Devices, Orthopedic/ Arthroscopic Medical Devices Gastroenterology Medical Devices and General Surgery Medical Devices) for Hospital and Home Healthcare: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021”.According to the report, the global reprocessed medical devices market was valued at approximately USD 1.42 billion in 2015 and is expected to reach approximately USD 4.02 billion by 2021, growing at a CAGR of around 19.7% between 2016 and 2021…

The market is primarily driven by the increasing significance and need for medical waste disposal. Favorable government initiatives are another key driving factor for reprocessed medical device market.Moreover, the growing concern regarding high volume of waste and landfills generated globally is influential in shifting the focus towards reprocessing of medical devices. However, reluctance in adopting reprocessed medical devices may hamper the market growth within the forecast period. Nonetheless, reduced product pricing of reprocessed devices is anticipated to open up new growth opportunities in the near future…

Read More.

Request a Sample of the Report here.

 

 

AMDR Welcomes the Pan American Health Organization and INVIMA to Hygia

AMDR welcomes the Pan American Health Organization and INVIMA, the Colombian Medical Product competent authority to Hygia!

 

 

 

 

 

We look forward to cooperating as PAHO contemplates a comprehensive, Pan American medical device regulation that addresses medical device reprocessing.

 

 

Interview: Where Do New Reprocessing Rules Leave EU?

medtech

 

 

 

Questions over proper oversight and allowances for reprocessing of single-use devices in the EU caused significant debate among policymakers who developed the pending European Medical Devices Regulation. Reprocessing advocate Dan Vukelich talked to Medtech Insight about whether or not there will be an EU-wide approach to device reprocessing under the new rules, and more about the path forward for the practice.

“Frankly, as SUD remanufacturers now need to meet all the same MD requirements as any other manufacturer and await member states to affirmatively opt in, the standard for SUD remanufacturing is now higher than it is for most manufacturers…”

Read More.  (Subscription required)

 

 

Association Between Surgeon Scorecard Use and Lower Operating Room Costs

Source: HPN Online

 

 

Despite the significant contribution of surgical spending to healthcare costs, most surgeons are unaware of their operating room (OR) costs. A study published in JAMA Surgery looked at the association of costs in the operating room.

The study showed that providing cost scorecards to surgeons during 1 year, combined with a small financial departmental incentive and identification of physician cost-saving champions, was associated with a significant reduction in surgical supply costs compared with surgeons who did not receive scorecards but were still eligible for the same financial incentive.

Read More.